Skip to main content

Table 4 Results of multivariate analysis of factors associated with herbal medicine use among patients diagnosed with hepatitis

From: Herbal medicine use among patients with viral and non-viral Hepatitis in Uganda: prevalence, patterns and related factors

Factor

Categories

Adjusted PRR

p-value

Socio-demographic

 Age groups

18–24

1

1

25–34

1.10 (0.88–1.34)

0.41

35–44

0.99 (0.75–1.29)

0.95

45–54

1.18 (0.93–1.49)

0.17

≥55

1.17 (0.79–1.76)

0.43

 Gender

Male

1

1

Female

0.94 (0.82–1.06)

0.31

 Education status

None

1

1

Primary

0.96 (0.83–1.10)

0.54

Secondary

1.00 (0.88–1.15)

0.95

Post-secondary

1.05 (0.89–1.25)

0.52

Clinical factors

 Current Diagnosis

Hep B

1

1

Hep B & C

0.52 (0.13–2.08)

0.36

Hep C

1.16 (1.07–1.31)

0.02

Others

1.04 (0.92–1.17)

0.52

 Time since diagnosis

<  6 months

1

1

6–12 months

0.96 (0.84–1.10)

0.52

13–24 months

0.69 (0.49–0.98)

0.03

>  24 months

0.77 (0.59–0.98)

0.05

 On conventional treatment

No

1

1

Yes

0.99 (0.87–1.15)

0.98

Safety profile

 Safe to use both

No

1

1

Yes

1.23 (1.05–1.43)

0.008

Not sure

1.32 (1.10–1.59)

0.003